Research project
Sean Lim - RAVE - CRUK (NAC) and Celldex : A phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies (RAVE study).
-
Lead researchers:
-
Other researchers:
-
Research funder:Cancer Research UK
-
Status:Not active
